Gene Expression Analysis of Immunomagnetically Enriched Circulating Tumor Cell Fraction in Castration-Resistant Prostate Cancer

被引：0
|
作者：
Markéta Škereňová
Veronika Mikulová
Otakar Čapoun
David Švec
Katarína Kološtová
Viktor Soukup
Hana Honová
Tomáš Hanuš
Tomáš Zima
机构：
[1] Charles University in Prague,Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine
[2] Charles University in Prague,Department of Urology, General University Hospital and First Faculty of Medicine
[3] Institute of Biotechnology CAS,Laboratory of Gene Expression
[4] Charles University in Prague,Institute of Laboratory Diagnostics, Third Faculty of Medicine
[5] Charles University in Prague,Department of Oncology, General University Hospital in Prague and First Faculty of Medicine
[6] Laboratory of Immunology and Allergology,undefined
来源：
Molecular Diagnosis & Therapy | 2018年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：381 / 390
页数：9
相关论文
共 50 条
  • [11] Circulating tumor cells in patients with castration-resistant metastatic prostate cancer
    Danila, D. C.
    Leversha, M. A.
    Gonzalez-Espinoza, R.
    Anand, A.
    Gu, B.
    Gignac, G. A.
    Larson, S.
    Heller, G.
    Fleisher, M.
    Scher, H. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [12] Treatment efficacy of carrelizumab in metastatic castration-resistant prostate cancer, and the significance of circulating tumor DNA fraction
    Zhou, Henan
    Chen, Yanning
    Zhang, Xiaonan
    Sang, Yuanyuan
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2022, 21 (02) : 425 - 432
  • [13] Prostein expression on circulating tumor cells as a prognostic marker in metastatic castration-resistant prostate cancer
    Zhenchao Zhang
    Rui Luo
    William K. Kelly
    Joshua Chen
    Shane Donahue
    Kevan Ip
    Nathan R. Handley
    William J. Tester
    Miranda L. Tsang
    Felix J. Kim
    Ronald Myers
    Grace Lu-Yao
    Jian Gu
    Jianqing Lin
    Bingshan Li
    Chun Wang
    Hushan Yang
    Prostate Cancer and Prostatic Diseases, 2024, 27 : 339 - 347
  • [14] Prostein expression on circulating tumor cells as a prognostic marker in metastatic castration-resistant prostate cancer
    Zhang, Zhenchao
    Luo, Rui
    Kelly, William K.
    Chen, Joshua
    Donahue, Shane
    Ip, Kevan
    Handley, Nathan R.
    Tester, William J.
    Tsang, Miranda L.
    Kim, Felix J.
    Myers, Ronald
    Lu-Yao, Grace
    Gu, Jian
    Lin, Jianqing
    Li, Bingshan
    Wang, Chun
    Yang, Hushan
    PROSTATE CANCER AND PROSTATIC DISEASES, 2024, 27 (02) : 339 - 347
  • [15] A Circulating Tumor Cell RNA Assay for Prognostication of Patients with Metastatic Castration-resistant Prostate Cancer
    Wang, Jasmine
    Kim, Minhyung
    Teng, Pai-Chi
    Jan, Yu Jen
    Chen, Jie-Fu
    Shi, Lucy Ruoxi
    You, Sungyong
    Tseng, Hsian-Rong
    Posadas, Edwin
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1568 - S1569
  • [16] Clinical phenotypes associated with circulating tumor cell enumeration in metastatic castration-resistant prostate cancer
    Bitting, Rhonda L.
    Healy, Patrick
    Halabi, Susan
    George, Daniel J.
    Goodin, Michael
    Armstrong, Andrew J.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (03) : 110.e1 - 110.e9
  • [17] Circulating tumor DNA fraction (ctDNA) as a surrogate predictive biomarker in metastatic castration-resistant prostate cancer (mCRPC).
    Conteduca, Vincenza
    Wetterskog, Daniel
    Scarpi, Emanuela
    Romanel, Alessandro
    Gurioli, Giorgia
    Jayaram, Anuradha
    Lolli, Cristian
    Schepisi, Giuseppe
    Casadei, Chiara
    Menna, Cecilia
    Wingate, Anna
    Demichelis, Francesca
    De Giorgi, Ugo
    Attard, Gerhardt
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [18] Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancer
    Sonpavde, Guru
    Agarwal, Neeraj
    Pond, Gregory Russell
    Nagy, Rebecca J.
    Nussenzveig, Roberto H.
    Hahn, Andrew W.
    Sartor, Oliver
    Gourdin, Theodore Stewart
    Nandagopal, Lakshminarayanan
    Ledet, Elisa M.
    Naik, Gurudatta
    Armstrong, Andrew J.
    Wang, Jue
    Bilen, Mehmet Asim
    Gupta, Shilpa
    Grivas, Petros
    Pal, Sumanta K.
    Lanman, Richard B.
    Talasaz, AmirAli
    Lilly, Michael B.
    CANCER, 2019, 125 (09) : 1459 - 1469
  • [19] The End of the Beginning: Circulating Tumor Cells As a Biomarker in Castration-Resistant Prostate Cancer
    Friedlander, Terence W.
    Fong, Lawrence
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (11) : 1104 - +
  • [20] Prognosis of metastatic castration-resistant prostate cancer in response to chemotherapy and PSMA expression in circulating tumor cells
    Nagaya, N.
    Nagata, M.
    Ashizawa, T.
    Lu, Y.
    Fujita, K.
    Horie, S.
    ANNALS OF ONCOLOGY, 2023, 34 : S1579 - S1580
12345